Pregled bibliografske jedinice broj: 1218520
Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity.
Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity. // European journal of immunology, 52 (2022), 6; 946-946 doi:10.1002/eji.202149491 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1218520 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Altered IgG glycosylation at COVID-19 diagnosis
predicts disease severity.
Autori
Vicente, Manuel M. ; Alves, Ines ; Gaifem, Joana ; Rodrigues, Claudia S. ; Fernandes, Angela ; Dias, Ana M. ; Štambuk, Jerko ; Petrović, Tea ; Oliveira, Pedro ; Ferreira-da-Silva, Frederico ; Soares, Adriana ; Seixas, Nair ; Teixeira, Tiago ; Malheiro, Luis ; Abreu, Miguel M. ; Lauc, Gordan ; Castro, Rui Sarmento E. ; Pinho, Salome S.
Izvornik
European journal of immunology (0014-2980) 52
(2022), 6;
946-946
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Inflammation ; agalactosylation ; asialylation ; COVID‐19 ; IgG Fc glycosylation ; SARS‐CoV‐2
Sažetak
The nature of the immune responses associated with COVID‐19 pathogenesis and disease severity, as well as the breadth of vaccine coverage and duration of immunity, is still unclear. Given the unpredictability for developing a severe/complicated disease, there is an urgent need in the field for predictive biomarkers of COVID‐19. We have analyzed IgG Fc N‐glycan traits of 82 SARS‐CoV‐2+ unvaccinated patients, at diagnosis, by nano‐LC‐ESI‐MS. We determined the impact of IgG Fc glyco‐variations in the induction of NK cells activation, further evaluating the association between IgG Fc N‐glycans and disease severity/prognosis. We found that SARS‐CoV‐2+ individuals display, at diagnosis, variations in the glycans composition of circulating IgGs. Importantly, levels of galactose and sialic acid structures on IgGs are able to predict the development of a poor COVID‐19 disease. Mechanistically, we demonstrated that a deficiency on galactose structures on IgG Fc in COVID‐19 patients appears to induce NK cells activation associated with increased release of IFN‐γ and TNF‐α, which indicates the presence of pro‐ inflammatory immunoglobulins and higher immune activation, associated with a poor disease course. This study brings to light a novel blood biomarker based on IgG Fc glycome composition with capacity to stratify patients at diagnosis.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
GENOS d.o.o.
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE